AcquisitionOther
Remix Therapeutics, Inc. acquired Passage Bio, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Remix Therapeutics, Inc. -> Passage Bio, Inc. · $100 million
To combine and operate as Remix Therapeutics, advancing RNA processing modulation therapies.
Open source record (SEC) ↗